ArticleAnnals of surgery open : perspectives of surgical history, education, and clinical approaches2025
Impact of Perioperative Hemoglobin A1c Levels on Survival Outcomes of Patients With Pancreatic Cancer: A Retrospective Study.
Article in Annals of surgery open : perspectives of surgical history, education, and clinical approaches, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to clarify the association between perioperative hemoglobin A1c (HbA1c) levels and survival outcomes in pancreatic cancer (PC) patients. Background: Diabetes mellitus is frequently associated with PC and may affect survival outcomes. Methods: We retrospectively analyzed 569 patients who underwent pancreatectomy for PC with available preoperative HbA1c (HbA1c-pre) data (2002-2018). A subgroup analysis included 318 patients with HbA1c measured 1 year postsurgery (HbA1c-1Y). Results: Optimal cutoff values were 9.0 for HbA1c-pre and 10.0 for HbA1c-1Y. Patients with HbA1c-pre ≥9.0 had worse relapse-free survival (RFS; median, 11.8 vs. 16.3 months, Conclusions: HbA1c-pre ≥9.0 and HbA1c-1Y ≥10.0 were prognostic factors in PC. Postoperative follow-up for diabetes mellitus is important, particularly following DP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.